Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.41775
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, a...

37.89 -0.35 (-0.92%)

71.45% Gain from 52W Low

549.5K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.0 / 100

Technically Neutral

50.7 / 100

1Yr Price target upside is 56%

14 analysts

Celldex Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, a...

71.45% Gain from 52W Low

SWOT Analysis

Celldex Therapeutics Inc Live Price Chart

Celldex Therapeutics Inc Live Price Chart